Treatment outcome | ARMS | ||
---|---|---|---|
Nevirapine (N = 125) | Efavirenz (N = 63) | Control (N = 73) | |
ETF n, (%) | 0 | 0 | 0 |
LTF n, (%) | 3 (2.4) | 11 (17.5) | 4 (5.5) |
LPF n, (%) | 0 | 0 | 0 |
ACPR n, (%) | 122 (97.6) | 52 (82.5) | 69 (94.5) |
 | RR = 0.4, 95% C.I = 0.29-0.9, P = 0.53 | RR = 3.2, 95% CI, 2.4-7.8, P < 0.001 |